Assessment of an Equimolar Mixture of Oxygen and Nitrous Oxide: Effects in Pediatric Dentistry.

Equimolar mixture of oxygen and nitrous oxide Observational study Substance-related disorders

Journal

International journal of clinical pediatric dentistry
ISSN: 0974-7052
Titre abrégé: Int J Clin Pediatr Dent
Pays: India
ID NLM: 101585405

Informations de publication

Date de publication:
Historique:
entrez: 23 5 2020
pubmed: 23 5 2020
medline: 23 5 2020
Statut: ppublish

Résumé

Many studies were conducted to assess the benefit/risk of equimolar mixture of oxygen and nitrous oxide (EMONO), but evaluating the appetite associated to its use is now getting very little attention in the literature. The purpose of this study was to investigate the effects present, felt, and sought during care by the child related with the 50% nitrous oxide/oxygen (EMONO) sedation used in pediatric dentistry. All patients in consultation with the Dental Service of Nantes hospital and in need of EMONO were included in the study. In this prospective single-center study, the effects present, felt, and sought during care by the child and the assessment of EMONO appreciation were recorded. The presence of clear signs that the child was trying to extend the duration of the EMONO use was also sought. Only 62% of the patients were presented with an anxiolytic effect, and 40% relative analgesia. Both effects were associated in 33% of children. Over the 76 patients assessed, 12 attempted to extend the duration of the EMONO use (16%). After a bivariate statistical analysis, none of the variables appeared significantly associated with the extension of the EMONO use duration. The significant proportion of patients who have prolonged the EMONO use seems to indicate a real attraction for nitrous oxide. This is the first study to evaluate nitrous oxide appreciation on a child. Prud'homme T, Allio A, Dajean-Trutaud S,

Sections du résumé

BACKGROUND BACKGROUND
Many studies were conducted to assess the benefit/risk of equimolar mixture of oxygen and nitrous oxide (EMONO), but evaluating the appetite associated to its use is now getting very little attention in the literature. The purpose of this study was to investigate the effects present, felt, and sought during care by the child related with the 50% nitrous oxide/oxygen (EMONO) sedation used in pediatric dentistry.
MATERIALS AND METHODS METHODS
All patients in consultation with the Dental Service of Nantes hospital and in need of EMONO were included in the study. In this prospective single-center study, the effects present, felt, and sought during care by the child and the assessment of EMONO appreciation were recorded. The presence of clear signs that the child was trying to extend the duration of the EMONO use was also sought.
RESULTS RESULTS
Only 62% of the patients were presented with an anxiolytic effect, and 40% relative analgesia. Both effects were associated in 33% of children. Over the 76 patients assessed, 12 attempted to extend the duration of the EMONO use (16%). After a bivariate statistical analysis, none of the variables appeared significantly associated with the extension of the EMONO use duration.
CONCLUSION CONCLUSIONS
The significant proportion of patients who have prolonged the EMONO use seems to indicate a real attraction for nitrous oxide. This is the first study to evaluate nitrous oxide appreciation on a child.
HOW TO CITE THIS ARTICLE UNASSIGNED
Prud'homme T, Allio A, Dajean-Trutaud S,

Identifiants

pubmed: 32440050
doi: 10.5005/jp-journals-10005-1658
pmc: PMC7229361
doi:

Types de publication

Journal Article

Langues

eng

Pagination

429-436

Informations de copyright

Copyright © 2019; Jaypee Brothers Medical Publishers (P) Ltd.

Déclaration de conflit d'intérêts

Source of support: Nil Conflict of interest: None

Références

Br Dent J. 2007 Dec 8;203(11):629-31
pubmed: 18065980
Subst Abus. 2019;40(1):33-42
pubmed: 30913001
Best Pract Res Clin Anaesthesiol. 2005 Sep;19(3):381-9
pubmed: 16013688
Drug Saf. 2006;29(7):633-40
pubmed: 16808555
Int J Drug Policy. 2009 Jan;20(1):62-9
pubmed: 18068967
Clin Oral Investig. 2012 Apr;16(2):633-42
pubmed: 22186944
Dent Assist. 2013 Jul-Aug;82(4):12, 14-6, 18-9; quiz 20-1
pubmed: 24003604
J Epidemiol Community Health. 2015 Apr;69(4):354-60
pubmed: 25538256
BMC Clin Pharmacol. 2008 Jun 11;8:3
pubmed: 18547418
Dent Update. 2013 Dec;40(10):822-4, 826-9
pubmed: 24597026
Therapie. 2016 Apr;71(2):179-86
pubmed: 27080836
J Fam Psychol. 2015 Feb;29(1):39-48
pubmed: 25419913
Drug Alcohol Depend. 2003 Jun 5;70(3 Suppl):S41-54
pubmed: 12759196
Int J Paediatr Dent. 2012 Sep;22(5):324-30
pubmed: 22092785
Dent Update. 2000 Apr;27(3):141-2, 144, 146
pubmed: 11218285
J Pharmacol Exp Ther. 1990 Dec;255(3):1246-55
pubmed: 2262904
Addict Behav. 2000 Sep-Oct;25(5):769-74
pubmed: 11023017
J Adolesc Health. 2008 Jan;42(1):36-42
pubmed: 18155028
Pediatrics. 2000 Apr;105(4):E47
pubmed: 10742368

Auteurs

Tony Prud'homme (T)

Pediatric Dentistry Department, CHU/Université Nantes, France; UMR 1246 - SPHERE "Methods in Patient-centered outcomes and health research", Université Nantes et Tours, France.

Adrien Allio (A)

Pharmacology Department-Addictovigilance, CHU/Université Nantes, France.

Sylvie Dajean-Trutaud (S)

Pediatric Dentistry Department, CHU/Université Nantes, France.

Samuel Bulteau (S)

Addictology and Psychiatry Department, CHU/Université Nantes, France.

Morgane Rousselet (M)

Pharmacology Department-Addictovigilance, CHU Nantes, France; Addictology and Psychiatry Department, CHU/Université Nantes, France; UMR 1246 - SPHERE "Methods in Patient-centered outcomes and health research", Université Nantes et Tours, France.

Serena Lopez-Cazaux (S)

Pediatric Dentistry Department, CHU/Université Nantes, France.

Isabelle Hyon (I)

Pediatric Dentistry Department, CHU/Université Nantes, France.

Marie Grall-Bronnec (M)

Pharmacology Department-Addictovigilance, CHU Nantes, France; Addictology and Psychiatry Department, CHU/Université Nantes, France; UMR 1246 - SPHERE "Methods in Patient-centered outcomes and health research", Université Nantes et Tours, France.

Caroline Victorri-Vigneau (C)

Pharmacology Department-Addictovigilance, CHU/Université Nantes, France; UMR 1246 - SPHERE "Methods in Patient-centered outcomes and health research", Université Nantes et Tours, France.

Classifications MeSH